KRAS and neoplasm: Using a synthetic lethal RNAi screening approach, White and colleagues identified KRAS and LKB1 co-mutant NSCLC tumours to be addicted to coatomer complex I (COPI)-dependent lysosome acidification that supplied macromolecules to the TCA cycle.